Company Filing History:
1 out of 86 
1 out of 43 Years Active: 2020
Title: Koichi Fujisawa: Innovator in Regenerative Medicine
Introduction
Koichi Fujisawa is a notable inventor based in Ube, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the evaluation and cultivation of mesenchymal stem cells. His innovative work has the potential to impact therapeutic approaches for liver dysfunction.
Latest Patents
Fujisawa holds a patent for a method that evaluates mesenchymal stem cell activity, as well as methods for culturing these cells and producing therapeutic agents for liver dysfunction. This patent outlines a comprehensive approach that includes an assay step for measuring the amount of adenylate kinase 4 (AK4) in mesenchymal stem cells. The determination of the activity level of these cells is based on the assayed amount of AK4, which is crucial for advancing regenerative medicine techniques.
Career Highlights
Throughout his career, Fujisawa has worked with esteemed institutions such as Yamaguchi University and Shibuya Corporation. His experience in these organizations has allowed him to develop and refine his innovative methods in stem cell research.
Collaborations
Fujisawa has collaborated with notable colleagues, including Isao Sakaida and Shuji Terai. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Koichi Fujisawa's work in evaluating and cultivating mesenchymal stem cells represents a significant advancement in regenerative medicine. His innovative methods hold promise for improving therapeutic strategies for liver dysfunction.